IgC Bio

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

No changes recorded yet. Missing observations do not mean the company has not changed.

Companies in the same space

Competitors picked by an AI model from the funded startups with the most similar descriptions, judged on those descriptions only. A reading, not a verified market map.

• Scala Biodesign scala-bio.comDirect competitorBoth offer computational platforms that explicitly design and optimize antibodies.
• Ainnocence, Inc. ainnocence.comDirect competitorBoth focus on de novo antibody design and protein engineering using AI platforms.
• Absci absci.comDirect competitorBoth use generative AI to design novel antibody or biologic therapeutics in silico.
• immunitoAI immunitoai.comDirect competitorBoth design de novo antibody therapeutics using structure‑aware AI platforms.
• Helixon helixon.comDirect competitorBoth use AI-driven platforms to design next‑generation therapeutic antibodies.
• Nabla Bio nabla.bioDirect competitorBoth run AI-driven platforms for rational antibody and protein therapeutic design.
• Galux galux.co.krPartial overlapBoth use AI for de novo antibody and protein therapeutic design.
• BigHat Biosciences bighatbio.comPartial overlapBoth use AI-guided platforms for antibody discovery and engineering.